Chris Gunter is senior adviser to the director of the U.S. National Human Genome Research Institute in Bethesda, Maryland.
Chris Gunter
Associate Professor
Emory University
From this contributor
Call to update standards for publishing autism research
Autism researchers should take steps to communicate their findings before, during and after publication of the paper.
Call to update standards for publishing autism research
By
Chris Gunter
1 December 2015 | 4 min read
Communication lapses hinder autism research
The term ‘deficit model’ traditionally means treating people with autism by focusing on their limitations rather than their strengths. Chris Gunter introduces the deficit model in a different context: science communication.
Great sequencing power — great responsibility
Chris Gunter and Daniel MacArthur discuss guidelines for assessing the evidence that a genetic variant causes autism or another disorder.
Great sequencing power — great responsibility
By
Chris Gunter, Daniel MacArthur
6 June 2014 | 4 min read
Explore more from The Transmitter
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
By
Claudia López Lloreda
2 October 2025 | 6 min read
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
By
Calli McMurray
2 October 2025 | 10 min read
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
By
Brendan Borrell
1 October 2025 | 11 min read